Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Malaria Journal|August 25, 2023
House modifications as a malaria control tool: how does local context shape participants' experience and interpretation in Uganda?Miriam Kayendeke, Christine Nabirye, Susan Nayiga, et al.AIDS and Behavior|September 16, 2008
Determinants of consistent condom use vary by partner type among young men in Kisumu, Kenya: a multi-level data analysisNelli Westercamp, Christine L Mattson, Michelle Madonia, et al.Malaria Journal|June 30, 2021
Effectiveness of in-service training plus the collaborative improvement strategy on the quality of routine malaria surveillance data: results of a pilot study in Kayunga District, UgandaNelli Westercamp, Sarah G Staedke, Catherine Maiteki-Sebuguzi, et al.Malaria Journal|June 16, 2026
The Malaria Vaccine Implementation Programme reduced clinical malaria in Kenya, 2020 to 2022 : Impact evaluation with predictive time-series models of routine surveillance dataJohn A Painter, Erika Wallender, Andrew N Hill, et al.Emerging Infectious Diseases|February 24, 2022
Plasmodium falciparum pfhrp2 and pfhrp3 Gene Deletions from Persons with Symptomatic Malaria Infection in Ethiopia, Kenya, Madagascar, and RwandaEric Rogier, Jessica N McCaffery, Doug Nace, et al.Malaria Journal|August 16, 2020
Assessment of molecular markers of anti-malarial drug resistance among children participating in a therapeutic efficacy study in western KenyaWinnie Chebore, Zhiyong Zhou, Nelli Westercamp, et al.BMC Infectious Diseases|March 16, 2019
The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected CambodiansLek Dysoley, Saorin Kim, Sergio Lopes, et al.Vaccine|November 15, 2025
Value profile for Malaria vaccines and monoclonal antibodiesAshley J Birkett, Evelyn Ansah, Scott Gordon, et al.Malaria Journal|April 22, 2026
The Malaria Vaccine Programme Evaluation in Kenya: results of a baseline household survey prior to the introduction of the RTS,S/AS01 vaccineNelli Westercamp, Isabella Nyangau, Titus K Kwambai, et al.The Lancet. Global Health|September 20, 2025
Sustained efficacy of the RTS,S/AS01E malaria vaccine over 50 months of follow-up when used in full-dose or fractional-dose regimens in young children in Ghana and Kenya: final results from an open-label, phase 2b, randomised controlled trialLawrence Osei-Tutu, Simon K Kariuki, Cynthia K Lee, et al.Pageof 3